Amylin Pharmaceuticals, Llc And Anr v. Assistant Controller Of Patents And Designs

175779201

Amylin Pharmaceuticals appealed the Assistant Controller's rejection of its patent application for 'RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS'. The appeal challenged the finding that the invention lacked inventive step and fell under Section 3(d).

Jurisdiction
India
Court
Delhi High Court
Case Number
175779201
Decision Date
24 November 2025

Detailed Summary

Amylin Pharmaceuticals appealed the Assistant Controller's rejection of its patent application for 'RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS'. The appeal challenged the finding that the invention lacked inventive step and fell under Section 3(d).

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Amylin Pharmaceuticals, Llc And Anr vs Assistant Controller Of Patents And Designs is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent120147074

Hindustan Unilever LimitedvsShree Shyam Udyog and Ors.

Hindustan Unilever Limited filed a suit against Shree Shyam Udyog for infringing its registered trade marks (SUNLIGHT) and copyrighted artistic packaging/trade dress. The court granted leave under Clause XIV of the Letters Patent Act and decreed the suit.

patent116558671

Havells India LtdvsMohit Talwar & Ors.

Havells India Ltd filed a suit against Mohit Talwar & Ors. concerning alleged infringement of its registered designs and trademark on Distribution Boards. The current order addresses an application seeking modification of the interim injunction, which required the Commissioner of Customs to stop the export of infringing products. To facilitate compliance with this suspension order, the court directed the defendants (No. 1, 2, and 3) to provide their Importer Exporter Code (IEC) details to enable effective enforcement.

patent121510056

Panacea Biotec LimitedvsSanofi Healthcare India Private Limited

Panacea Biotec Limited filed a patent infringement suit against Sanofi Healthcare India Private Limited concerning the product Shan6, which allegedly infringes IN 351. The parties reached an amicable resolution and settled the dispute before the Delhi High Court.

patent178979917

Emd Millipore CorporationvsAssistant Controller Of Patents And Designs

The Delhi High Court heard several part-heard matters. In C.A.(COMM.IPD-PAT) 16/2023, the court noted that the Patent Office had submitted a report concerning issues related to inventive steps, subject matter eligibility, and amendment under the Patents Act, 1970.

patent110364234

Neela Film Productions Private LimitedvsTaarakmehtakaooltahchashmah.Com & Ors.

The Delhi High Court issued several procedural orders in favor of Neela Film Productions Private Limited (Plaintiff) in its copyright and trademark infringement suit against Taarakmehtakaooltahchashmah.Com & Ors. (Defendants). The court granted exemptions from pre-institution mediation, allowed the plaintiff to serve advance copies on a specific defendant despite lack of contact details, and directed that the plaint be formally registered as a commercial suit. These orders pave the way for the substantive trial concerning the alleged infringement of the popular show 'Taarak Mehta Ka Ooltah Chashmah'.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call